Literature DB >> 25183938

Role of kidney biomarkers of chronic kidney disease: An update.

Zeba Khan1, Manoj Pandey1.   

Abstract

Chronic kidney disease (CKD) is a progressive pathological condition marked by deteriorating renal function over time. Diagnostic of kidney disease depend on serum creatinine level and glomerular filtration rate which is detectable when kidney function become half. The detection of kidney damage in an early stage needs robust biomarkers. Biomarkers allow monitoring the disease progression at initial stages of disease. On the onset of impairment in cellular organization there is perturbation in signaling molecules which are either up-regulated or down-regulated and act as an indicator or biomarker of diseased stage. This review compiled the cell signaling of different kidney biomarkers associated with the onset of chronic kidney diseases. Delay in diagnosis of CKD will cause deterioration of nephron function which leads to End stage renal disease and at that point patients require dialysis or kidney transplant. Detailed information on the complex network in signaling pathway leading to a coordinated pattern of gene expression and regulation in CKD will undoubtedly provide important clues to develop novel prognostic and therapeutic strategies for CKD.

Entities:  

Keywords:  Biomarker; Cell signaling; Clusterin; Kidney; NGAL

Year:  2014        PMID: 25183938      PMCID: PMC4150227          DOI: 10.1016/j.sjbs.2014.07.003

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 1319-562X            Impact factor:   4.219


  50 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

Review 3.  Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.

Authors:  B Shannan; M Seifert; K Leskov; J Willis; D Boothman; W Tilgen; J Reichrath
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

Review 4.  Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse.

Authors:  L Kjeldsen; J B Cowland; N Borregaard
Journal:  Biochim Biophys Acta       Date:  2000-10-18

5.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

6.  An iron delivery pathway mediated by a lipocalin.

Authors:  Jun Yang; David Goetz; Jau Yi Li; Wenge Wang; Kiyoshi Mori; Daria Setlik; Tonggong Du; Hediye Erdjument-Bromage; Paul Tempst; Roland Strong; Jonathan Barasch
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

Review 7.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

8.  Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney.

Authors:  J R Saunders; A Aminian; J L McRae; K A O'Farrell; W R Adam; B F Murphy
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

9.  Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin.

Authors:  Alessandro E Caccamo; Maurizio Scaltriti; Andrea Caporali; Domenico D'Arca; Francesca Scorcioni; Serenella Astancolle; Massimo Mangiola; Saverio Bettuzzi
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

10.  Short-term information processing, long-term responses: Insights by mathematical modeling of signal transduction. Early activation dynamics of key signaling mediators can be predictive for cell fate decisions.

Authors:  Annette Schneider; Ursula Klingmüller; Marcel Schilling
Journal:  Bioessays       Date:  2012-04-23       Impact factor: 4.345

View more
  5 in total

1.  Shen-Kang protects 5/6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways.

Authors:  Meiyou Liu; Jisoo Park; Xiaoxiao Wu; Yuwen Li; Quangdon Tran; Kisun Mun; Yongjin Lee; Gang Min Hur; Aidong Wen; Jongsun Park
Journal:  Int J Mol Med       Date:  2015-08-26       Impact factor: 4.101

Review 2.  Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome.

Authors:  Jacek Rysz; Anna Gluba-Brzózka; Beata Franczyk; Zbigniew Jabłonowski; Aleksandra Ciałkowska-Rysz
Journal:  Int J Mol Sci       Date:  2017-08-04       Impact factor: 5.923

3.  Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.

Authors:  Xian-Fei Zeng; Dong-Xue Lu; Jun-Min Li; Yun Tan; Zhuo Li; Lei Zhou; Zeng-Qian Xi; Shu-Miao Zhang; Wei Duan
Journal:  BMC Nephrol       Date:  2017-07-12       Impact factor: 2.388

4.  Alisol A 24-Acetate and Alisol B 23-Acetate Induced Autophagy Mediates Apoptosis and Nephrotoxicity in Human Renal Proximal Tubular Cells.

Authors:  Chunfei Wang; Liang Feng; Liang Ma; Haifeng Chen; Xiaobin Tan; Xuefeng Hou; Jie Song; Li Cui; Dan Liu; Juan Chen; Nan Yang; Jing Wang; Ying Liu; Bingjie Zhao; Gang Wang; Yuanli Zhou; Xiaobin Jia
Journal:  Front Pharmacol       Date:  2017-03-31       Impact factor: 5.810

5.  Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis.

Authors:  Hassan Askari; Behjat Seifi; Mehri Kadkhodaee; Nima Sanadgol; Mohammed Elshiekh; Mina Ranjbaran; Parisa Ahghari
Journal:  EXCLI J       Date:  2018-01-02       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.